PharmaKB logo
Company Reports
Company Reports
Drug Reports
Drug Reports
Disease Reports
Disease Reports
Sets
Sets
Favorites
Favorites
Log in
Log in
AboutPricing
Company ReportsSarfez Pharmaceuticals
Sarfez Pharmaceuticals
Download report
Favorite
Financial
Marketed Drugs
Clinical Trials
Financial
Stock price
No data
Company Revenue
No data
Revenue by Drug
Loading
Marketed Drugs
Therapeutic Areas:
All
Classification:
All
Include Generics:
Trade Name
Drug Name
Approved
Patent Expires
Indication
SoaanzTorsemide2021-06-142033
Heart failure
,
Hypertension
,
Chronic kidney failure
,
Liver cirrhosis
,
Nephrotic syndrome
,
Edema
,
Ascites
,
Pulmonary edema
Clinical Trials
Therapeutic Areas:
All
Classification:
All
Approval:
All
Status:
All
Phases:
All
Drug Name
Phase 1
Phase 2
Phase 3
Phase 4
Indication
Torsemide
food-drug interactions
,
chronic renal insufficiency
,
body weight changes
,
overactive urinary bladder
,
urinary incontinence
,
healthy volunteers/patients
,
heart failure
,
edema
,
iron overload
Spirolactone
healthy volunteers/patients
,
diabetic nephropathies
,
kidney diseases
,
diabetes mellitus
,
heart failure
,
type 2 diabetes mellitus
,
glucose intolerance
,
hypertension
,
hypercholesterolemia
,
proteinuria
Histone-arginine methyltransferase carm1
hereditary angioedemas
,
angioedema
,
hereditary angioedema types i and ii
,
hereditary angioedema type iii
Surlorian
covid-19
,
breast neoplasms
,
rheumatoid arthritis
,
arthritis
,
follicular lymphoma
,
necrosis
,
lung diseases
,
interstitial lung diseases
Isoxaflutole
epilepsy
,
multiple sclerosis
,
fibrosis
,
autoimmune diseases
,
healthy volunteers/patients
,
beta-thalassemia
,
thalassemia
,
iron overload
,
whooping cough
,
tetanus
,
diphtheria
,
tetany
,
aging
,
chronic renal insufficiency
,
kidney diseases
© 2020-2025 Collaborative Drug Discovery Inc. (CDD) | Terms of Use